0.9 USD
+0.03 (+3.41%)
0.8005 USD
-0.1 (-11.06%)
ChartMill assigns a Buy % Consensus number of 80% to ACER. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.53. This target is 70% above the current price.
ACER was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ACER.
In the previous month the buy percentage consensus was at a similar level.
ACER was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-09-05 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-09-01 | Roth MKM | Downgrade | Buy -> Neutral |
| 2023-09-01 | Roth Capital | Downgrade | Buy -> Neutral |
| 2023-03-28 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-20 | EF Hutton | Reiterate | Buy |
| 2022-02-02 | EF Hutton | Initiate | Buy |
ACER THERAPEUTICS INC / ACER FAQ
What do analysts expect the price target to be for ACER THERAPEUTICS INC (ACER)?
8 analysts have analysed ACER and the average price target is 1.53 USD. This implies a price increase of 70% is expected in the next year compared to the current price of 0.9.
Can you provide the consensus rating for ACER THERAPEUTICS INC stock?
The consensus rating for ACER THERAPEUTICS INC (ACER) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.